Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systemic infection
A Synowiec, A Szczepański… - Clinical microbiology …, 2021 - Am Soc Microbiol
To date, seven identified coronaviruses (CoVs) have been found to infect humans; of these,
three highly pathogenic variants have emerged in the 21st century. The newest member of …
three highly pathogenic variants have emerged in the 21st century. The newest member of …
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
The global coronavirus disease 2019 (COVID-19) pandemic is currently ongoing. It is
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A high …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A high …
Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma
Abstract Plasma SARS-CoV-2 RNA may represent a viable diagnostic alternative to
respiratory RNA levels, which rapidly decline after infection. Quantitative PCR with reverse …
respiratory RNA levels, which rapidly decline after infection. Quantitative PCR with reverse …
Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into a major
pandemic called coronavirus disease 2019 (COVID-19) that has created unprecedented …
pandemic called coronavirus disease 2019 (COVID-19) that has created unprecedented …
The role of angiotensin converting enzyme 2 in modulating gut microbiota, intestinal inflammation, and coronavirus infection
JM Penninger, MB Grant, JJY Sung - Gastroenterology, 2021 - Elsevier
The role of angiotensin converting enzyme 2 has expanded from regulating the renin
angiotensin system to regulating intestinal amino acid homeostasis and the gut microbiome …
angiotensin system to regulating intestinal amino acid homeostasis and the gut microbiome …
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
Covid‐19 and oral diseases: Crosstalk, synergy or association?
DA Brandini, AS Takamiya, P Thakkar… - Reviews in medical …, 2021 - Wiley Online Library
Summary The coronavirus disease 2019 (Covid‐19) is a viral infection caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that clinically affects multiple …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that clinically affects multiple …
Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Background Real-world evidence on the association between autoimmune inflammatory
rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are …
rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are …
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: a systematic review and meta‐analysis
Background The risk of severe acute respiratory syndrome‐related coronavirus 2 (SARS‐
CoV‐2) infection and clinical outcomes of coronavirus disease (COVID‐19) in inflammatory …
CoV‐2) infection and clinical outcomes of coronavirus disease (COVID‐19) in inflammatory …
[HTML][HTML] COVID-19 and cancer comorbidity: therapeutic opportunities and challenges
AS Pathania, P Prathipati, BAA Abdul, S Chava… - Theranostics, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) is a viral disease caused by a novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the respiratory …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the respiratory …